72.17BMarket Cap17.13P/E (TTM)
183.90High176.57Low4.49KlotVolume183.00Open182.57Pre Close80.54MTurnover0.50%Turnover RatioLossP/E (Static)401.00MShares215.7152wk High14.95P/B16.28BFloat Cap76.3252wk Low219.08Limit Up90.45MShs Float215.71Historical High146.06Limit Down4.02%Amplitude28.75Historical Low--Dividend TTM179.40Avg Price2.25KlotAsk--Div YieldTTM100Lot Size1.93KlotBid
Sichuan Biokin Pharmaceutical Stock Forum
December 22, 2023
2142.HK
1.56
(-2.5%)
The biopharma company has marked out a path to profitability by licensing its drug expertise and antibody platforms to partners such as Pfizer
Key Takeaways:
Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million and milestone payments of up to $1.05 billion
HBM Holdin...
No comment yet